Considering that FcγR-binding is involved in many of these mechanisms, it seems likely that a high sialylation of anti-β2GP1-IgG leads to a low pathogenicity of these autoantibodies and does not cause APS. The gene discussed is FCGR2A; the disease is autoimmune polyendocrinopathy.